PT1664061T - Processo para a síntese de compostos de morfinano e seus intermediários - Google Patents

Processo para a síntese de compostos de morfinano e seus intermediários

Info

Publication number
PT1664061T
PT1664061T PT47613328T PT04761332T PT1664061T PT 1664061 T PT1664061 T PT 1664061T PT 47613328 T PT47613328 T PT 47613328T PT 04761332 T PT04761332 T PT 04761332T PT 1664061 T PT1664061 T PT 1664061T
Authority
PT
Portugal
Prior art keywords
intermediates
synthesis
morphinane compounds
morphinane
compounds
Prior art date
Application number
PT47613328T
Other languages
English (en)
Inventor
Smith Craig
Purcell Stuart
Waddell Lucy
Hayes Nicholas
Ritchie Jarrod
Brian Halliday Scott
Mitchell Melville
Scott Wilson George
Original Assignee
Glaxosmithkline Australia Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2003905153A external-priority patent/AU2003905153A0/en
Application filed by Glaxosmithkline Australia Pty Ltd filed Critical Glaxosmithkline Australia Pty Ltd
Publication of PT1664061T publication Critical patent/PT1664061T/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT47613328T 2003-09-22 2004-09-22 Processo para a síntese de compostos de morfinano e seus intermediários PT1664061T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2003905153A AU2003905153A0 (en) 2003-09-22 Chemical Compounds and Processes

Publications (1)

Publication Number Publication Date
PT1664061T true PT1664061T (pt) 2017-06-22

Family

ID=34318304

Family Applications (1)

Application Number Title Priority Date Filing Date
PT47613328T PT1664061T (pt) 2003-09-22 2004-09-22 Processo para a síntese de compostos de morfinano e seus intermediários

Country Status (7)

Country Link
EP (1) EP1664061B1 (pt)
JP (1) JP4879740B2 (pt)
CA (1) CA2539659C (pt)
ES (1) ES2627995T3 (pt)
HU (1) HUE034668T2 (pt)
PT (1) PT1664061T (pt)
WO (1) WO2005028483A1 (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2073636B1 (en) * 2006-10-17 2012-09-05 Penick Corporation Process for preparing oxymorphone
CA2674915C (en) * 2006-10-17 2015-06-30 Penick Corporation Process for preparing oxymorphone
AU2012216358B2 (en) * 2006-10-17 2014-11-20 Penick Corporation Process For Preparing Oxymorphone, Naltrexone and Buprenorphine
US20080125592A1 (en) 2006-10-17 2008-05-29 Penick Corporation Process for preparing oxymorphone, naltrexone, and buprenorphine
GB0624880D0 (en) 2006-12-14 2007-01-24 Johnson Matthey Plc Improved method for making analgesics
CA2681740A1 (en) 2007-03-23 2008-10-02 Mallinckrodt Inc. Improved preparation of oxymorphone from oripavine
MX2009010931A (es) 2007-04-16 2009-10-29 Mallinckrodt Inc Reduccion novedosa de opiaceos utilizando la reaccion de transferencia catalitica de hidrogeno.
WO2009067275A1 (en) * 2007-11-21 2009-05-28 Progenics Pharmaceuticals, Inc N-oxides of 4,5-epoxy-morphinanium analogs
NZ589867A (en) * 2008-06-20 2012-08-31 Tpi Entpr Pty Ltd Process for the synthesis of n-demethylated morphinane compounds
US8946419B2 (en) 2009-02-23 2015-02-03 Mallinckrodt Llc (+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives
WO2010096790A1 (en) 2009-02-23 2010-08-26 Mallinckrodt Inc. (+)-morphinananium n-oxides and processes for their production
US8829020B2 (en) 2009-07-16 2014-09-09 Mallinckrodt Llc Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers
WO2012020022A1 (en) * 2010-08-12 2012-02-16 Boehringer Ingelheim International Gmbh 6-cycloalkyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a inhibitors
CN103596962B (zh) * 2011-05-02 2017-02-15 布鲁克大学 通过使用环化脱水试剂的n‑氧化物的n‑脱甲基化制备吗啡类似物的方法和中间体
AU2012253188B2 (en) 2011-05-06 2016-12-22 Brock University Process for the preparation of morphine analogs via metal catalyzed N-demethylation/functionalization and intramolecular group transfer
EP2753622B1 (en) 2011-09-08 2016-01-20 Mallinckrodt LLC Production of alkaloids without the isolation of intermediates
IN2014DN07315A (pt) * 2012-02-03 2015-04-24 Univ Brock
GB201313915D0 (en) 2013-08-02 2013-09-18 Johnson Matthey Plc Process
WO2015015146A1 (en) 2013-08-02 2015-02-05 Johnson Matthey Public Limited Company Process for the preparation of oxymorphone
US20160052932A1 (en) * 2014-08-25 2016-02-25 Johnson Matthey Public Limited Company Processes for Making Opioids Including 14-Hydroxycodeinone and 14-hydroxymorphinone
ES2701855T3 (es) 2016-05-31 2019-02-26 Alcaliber Investig Desarrollo E Innovacion Slu Proceso para la obtención de 3,14-diacetiloximorfona a partir de oripavina

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3254088A (en) 1961-03-14 1966-05-31 Lewenstein Morphine derivative
GB939287A (en) * 1961-03-14 1963-10-09 Sankyo Co New morphinone and codeinone derivatives and process for preparing the same
US3332950A (en) 1963-03-23 1967-07-25 Endo Lab 14-hydroxydihydronormorphinone derivatives
US5869669A (en) 1996-07-26 1999-02-09 Penick Corporation Preparation of 14-hydroxynormorphinones from normorphinone dienol acylates
AUPQ968300A0 (en) * 2000-08-25 2000-09-21 Glaxo Wellcome Australia Ltd Chemical methods

Also Published As

Publication number Publication date
JP2007505935A (ja) 2007-03-15
EP1664061A4 (en) 2009-09-09
HUE034668T2 (hu) 2018-02-28
CA2539659C (en) 2013-03-26
EP1664061A1 (en) 2006-06-07
WO2005028483A1 (en) 2005-03-31
CA2539659A1 (en) 2005-03-31
EP1664061B1 (en) 2017-03-15
JP4879740B2 (ja) 2012-02-22
ES2627995T3 (es) 2017-08-01

Similar Documents

Publication Publication Date Title
PT1644384E (pt) Processo e intermediários para a síntese de entecavir
PT1664061T (pt) Processo para a síntese de compostos de morfinano e seus intermediários
TWI370811B (en) Process for the preparation of ring compounds
IL173456A0 (en) Process for the preparation of 4-amino-3-quinolinecarbonitriles
IL167426A (en) Process for the manufacture of valsartan
HUP0500851A3 (en) Process for the preparation of rosuvastatin
GB0623764D0 (en) Process for the synthesis of hydromorphone
PL1807395T3 (pl) Sposób syntezy n-alkoksyamin
IL180513A0 (en) Process for synthesis of 4-4'-diamino-diphenyl-sulfone
IL173736A0 (en) Process for the preparation of renzapride and intermediates thereof
IL223579A0 (en) Synthesis of amines and intermediates for the synthesis thereof
IL175743A0 (en) Process for the preparation of thiazolopyrimidines
SI1403264T1 (en) Process for the industrial synthesis of 5-amino-3-carboxymethyl-4-cyano-2-thiophenecarboxydimethylester
HUP0600231A2 (en) Novel process for the preparation of 2h-chromenes
AU2003242867A8 (en) Process for the synthesis of mosapride
AU2003246098A8 (en) Oxamidination process of carbonyl compounds
HK1095145A1 (en) Process for the preparation of n-arylmorpholinones n-
EG24122A (en) Process for the synthesis of 3-cyano-6-alkoxy-7-nitro-4-quinolines
SG111997A1 (en) Improved process for the preparation of polyalkylphenoxyaminoalkanes
PL371583A1 (en) Process for the preparation of 7alpha-methylsteroids
PL1622926T3 (pl) Nowy sposób i produkty pośrednie wytwarzania związków 19-norsteroidów fluorowcowanych w pozycji 17
IL164788A0 (en) Process for the preparation of 3-isochromanone
EP1539772A4 (en) PROCESS FOR PREPARING PHOSPHORDIAMIDITE COMPOUNDS
ZA200601986B (en) Process for the synthesis of 3-(3-fluoro-4-hydroxyphenyl)-7-hydroxynaphthonitrile
HK1087111A1 (en) Process for the preparation of nicotinaldehydes